Back to search

Ireland· IE-PA-PA23266/021/001

Piperacillin Tazobactam 2 g/0.25 g powder for solution for infusion

A piperacillin und beta-lactamase-inhibitor product containing piperacillin sodium + tazobactam (as sodium salt), registered in Ireland by Viatris Limited. The same ATC class is registered in 12 of our 19 countries.

ATC J01CR05

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedPiperacillin Tazobactam 2 g/0.25 g po…ATCJ01CR05REGISTER NO.IE-PA-PA23266/021/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Piperacillin und beta-lactamase-inhibitor is registered in 12 of 19 countries.

Countries holding a registration under ATC J01CR05 (piperacillin und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Piperacillin und beta-lactamase-inhibitor · ATC J01CR05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of piperacillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (14 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Piperacillin und beta-lactamase-inhibitor · price per daily dose (14 g)

USD · FX 28 Sept 2026

  • CH Switzerland$158.68
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Piperacillin sodium + Tazobactam (as sodium salt)
Manufacturer
Viatris Limited
Country
Ireland (IE)
ATC code
J01CR05
ATC class
Piperacillin und Beta-Lactamase-Inhibitor
Defined daily dose
14 g, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23266/021/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

111 interactions on record for piperacillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Piperacillin und beta-lactamase-inhibitor · interactions on record

111 records

  • 5 severe
  • 22 moderate
  • 4 minor
  • 80 info

Most severe, free to view

  • VancomycinA07AA09severe
  • VancomycinJ01XA01severe
  • MethotrexateL01BA01severe
  • MethotrexateL04AX03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Piperacillin und beta-lactamase-inhibitor in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All piperacillin und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Piperacillin/Tazobactam Aptapharma, Piperacillin/Tazobactam Ibigen
  • Belgium · Piperacillin/Tazobactam Eg (Eurogenerics), Piperacillin/Tazobactam Eugia
  • Bulgaria · Piperacillin/Tazobactam Kabi, Перазин
  • Cyprus · Pazoctam, Piperacillin + Tazobactam Viatris
  • Czechia · Apiz, Kezutin
  • Germany · Piperacillin Plus Tazobactam Eberth, Piperacillin/Tazobactam Accord
  • Denmark · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam B. Braun
  • Estonia · Eriz, Piperacillin/Tazobactam Eugia
  • Spain · Piperacilina/Tazobactam Accord Healthcare, Piperacilina/Tazobactam Aurovitas
  • Finland · Piperacillin / Tazobactam Qilu, Piperacillin/Tazobactam Antibiotice
  • France · Piperacilline Tazobactam Viatris, Piperacilline/Tazobactam Arrow
  • United Kingdom (Northern Ireland) · Piperacillin / Tazobactam Qilu, Piperacillin Tazobactam Mylan
  • Greece · Gramenox, Piperacillin + Tazobactam Viatris
  • Croatia · Acipirin, Piperacilin/Tazobaktam Accord
  • Hungary · Piperacillin/Tazobactam Aptapharma, Piperacillin/Tazobactam Kabi
  • Iceland · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam Sandoz
  • Italy · Ibitazina, Limerik
  • Lithuania · Eratia, Piperacillin/Tazobactam Kalceks
  • Luxembourg · Piperacillin/Tazobactam Eurogenerics, Piperacillin/Tazobactam Kabi
  • Latvia · Eratia, Piperacillin/Tazobactam Eugia
  • Malta · Piperacillin Tazobactam Viatris, Piperacillin/Tazobactam Aptapharma
  • Netherlands · Piperacillin/Tazobactam Tillomed, Piperacilline/Tazobactam Accord
  • Norway · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam B. Braun
  • Poland · Piperacillin + Tazobactam Accord, Piperacillin + Tazobactam Aptapharma
  • Portugal · Piperacilina + Tazobactam Accord, Piperacilina + Tazobactam Aurobindo
  • Romania · Perasin, Piperacilină/Tazobactam Aptapharma
  • Sweden · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam B. Braun
  • Slovenia · Piperacilin/Tazobaktam Accord, Piperacilin/Tazobaktam Aptapharma
  • Slovakia · Piperacilin Comp. Sandoz, Piperacillin/Tazobactam Aptapharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d545b062-5544-43df-8dca-5f511db08c0e
GET /v1/drugs/d545b062-5544-43df-8dca-5f511db08c0e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01CR",
    "J01CR05"
  ],
  "strength": null,
  "pa_number": "PA23266/021/001",
  "substances": [
    "Piperacillin sodium",
    "Tazobactam (as sodium salt)"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "26/02/2010",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about piperacillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.